Mayo Clinic Cancer Center (MCCC) CCSG Senior Leadership includes the Director, Deputy Director at Large, Deputy Director Clinical Research, Deputy Director Arizona, Deputy Director Florida, Deputy Director Administration, and 3 Associate Directors. There have been a number of changes since the last renewal. Given the size, complexity and geographical locations of our Cancer Center, a Deputy Director at Large was added to aid in the integration of our 3 site Cancer Center. Dr. Edith Perez currently serves in this role. Dr. Ruben Mesa has replaced Dr. Rafael Fonseca as Deputy Director MCCC Arizona as Dr. Fonseca stepped down to assume leadership responsibilities as Chair, Department of Medicine, Mayo Clinic in Arizona. Mr. Brian Nelson has replaced Mr. Michael Pfenning as senior administrator for MCCC. Mr. Pfenning stepped down to assume other leadership responsibilities at Mayo Clinic following 18 years with MCCC. To reflect the size and complexity of MCCC, Mr. Nelson assumed the role of Deputy Director Administration. Dr. Dan Billadeau replaced Dr. Edward Leof as Associate Director for Basic Science. Dr. Steven Russell replaced Dr. Robert Jenkins as Associate Director for Translational Research. Senior Leadership remaining unchanged are Dr. Robert Diasio, Director, Dr. Charles Erlichman, Deputy Director Clinical Research, Dr. Robert Smallridge, Deputy Director Florida, Dr. Gloria Petersen, Associate Director Population Sciences.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015083-40
Application #
8682951
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-04-25
Project End
2019-02-28
Budget Start
2014-07-11
Budget End
2015-02-28
Support Year
40
Fiscal Year
2014
Total Cost
$557,246
Indirect Cost
$206,778
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Basch, Ethan; Rogak, Lauren J; Dueck, Amylou C (2016) Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials. Clin Ther 38:821-30
Renner, Danielle N; Malo, Courtney S; Jin, Fang et al. (2016) Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model. Neurotherapeutics 13:226-36
Navari, Rudolph M; Qin, Rui; Ruddy, Kathryn J et al. (2016) Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting. N Engl J Med 375:134-42
Amirian, E Susan; Zhou, Renke; Wrensch, Margaret R et al. (2016) Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study. Cancer Epidemiol Biomarkers Prev 25:282-90
Cuellar-Partida, Gabriel; Lu, Yi; Dixon, Suzanne C et al. (2016) Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Hum Genet 135:741-56
Ye, Zi; Austin, Erin; Schaid, Daniel J et al. (2016) A multi-locus genetic risk score for abdominal aortic aneurysm. Atherosclerosis 246:274-9
McCormack, Valerie A; Burton, Anya; dos-Santos-Silva, Isabel et al. (2016) International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries. Cancer Epidemiol 40:141-51
Basal, E; Ayeni, T; Zhang, Q et al. (2016) Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer. Curr Mol Med 16:222-31
Vaidhyanathan, Shruthi; Wilken-Resman, Brynna; Ma, Daniel J et al. (2016) Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases. J Pharmacol Exp Ther 356:251-9
Yoon, H H; Foster, N R; Meyers, J P et al. (2016) Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance). Ann Oncol 27:339-44

Showing the most recent 10 out of 948 publications